Home » Archive

Drug Discovery

Drug Discovery, Events, Headline, SDBN Blog, SDBN Events »

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

Posted by Mary Canady August 3rd, 2012 .
No Comments

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and the University of California, San Diego, and the La Jolla Institute for Allergy and Immunology. This new “collaboratory” opened in November of 2011, ideally located between the institutions in La Jolla, and demonstrates the power and potential of working together to fight disease. At our SDBN event August 21st, Evan Snyder, M.D., Ph.D., director of …

More...

Drug Discovery, Headline »

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

Posted by Mary Canady June 4th, 2012 .
No Comments

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, beginning with their acquisition of SGX Pharmaceuticals and Applied Molecular Evolution, and they’ve continued to move forward and contribute to the region.

The SDBN is dedicated to helping the local life science community understand and leverage the fantastic opportunities available through networking and sharing resources. Lilly is a leader in this area and formed the Open …

More...

Diagnostics, Drug Development, Drug Discovery, Featured, SDBN Blog »

San Diego’s Biotechnology Companies: Who’s Taking Off?

Posted by Lara March 8th, 2012 .
No Comments

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  But we also found a net gain in companies, with 68 added. We’ve begun to add some of the ‘provenances’ of new companies, as well as what’s happened to those that are no longer listed, and welcome your comments and additions as well, please leave them as a comment below. Note that some companies …

More...

Drug Development, Drug Discovery, Headline, SDBN Blog, SDBN Events »

SDBN March 26th 2012 Event with Organovo

Posted by Mary Canady March 6th, 2012 .
No Comments

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been included in the MIT Technology Review’s 2012 TR50 list of the world’s most innovative companies. The excitement around Organovo has grown since they recently announced funding and their stock is now publicly traded. You’ll get the chance to hear from CEO Keith Murphy at our March 26th event, he’ll give a presentation titled ‘3D Bioprinting …

More...

Biotechnology, Conferences, Drug Discovery, Featured, SDBN Blog »

Focus on San Diego: Life Science Conferences Spring 2012

Posted by Mary Canady January 31st, 2012 .
No Comments

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be shared during these two months.  Our own Mary Canady will also be participating in a panel discussing on the triumphs and trials of Transitioning from Academia to Industry at the Annual meeting of the Biophysical Society on Tuesday, February 28, 2:30 PM – 4:00 PM.
We hope that you are planning on attending at least some …

More...

Drug Discovery, Featured, SDBN Blog, Uncategorized »

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

Posted by Lara July 28th, 2011 .
No Comments

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable insights and advice for scientists managing or considering how to manage an outsourced drug discovery project.
We’ve compiled some of the key tips and highlights of the night including:

What activities should you outsource?
Finding the right CRO for your objectives
Managing your CRO relationship successfully every time
Virtual tools to help manage and build your CRO network
Finding the funding …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events, Uncategorized »

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

Posted by Mary Canady July 1st, 2011 .
No Comments

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug companies are hungry for drug candidates to fill their pipelines. Additionally, the abundance of drug discovery contract research organizations (CROs), the ability to manage them remotely, and the ability to find partners and tools more easily on the internet presents an interesting opportunity.
Our July 19th event is our first in a series of Virtual Biotech …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events »

SDBN June 21st Event Featuring aTyr Pharma

Posted by Mary Canady May 27th, 2011 .
No Comments

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on physiocrines, small proteins involved in signaling pathways for areas such hematology, immunology, and metabolism disorders. The company was founded based on research which originated at the Scripps Research Institute, and Watkins’ title indicates the company is reaching beyond in vitro drug discovery to focus on biological processes. It will be exciting to see the …

More...

Drug Discovery, Headline, SDBN Events »

SDBN April 19th 2011 Event Featuring Celgene

Posted by Mary Canady March 22nd, 2011 .
No Comments

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one of the top ten fastest growing biotech stocks. Celgene has more than 4,000 employees worldwide, with important work being carried out at their San Diego location. David Webb, Vice President, Research & San Diego Site Director (Bio) will give a presentation titled “Celgene’s Drug Discovery Engine in San Diego” at our April 19th event.
As always, …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events, Uncategorized »

SDBN October 26th Event Featuring Trius Therapeutics

Posted by Mary Canady October 5th, 2010 .
No Comments

Trius Therapeutics is a great local company which recently had an initial public offering (IPO), quite a feat in this economy. What is the secret to their success? They focus on antibacterials for life threatening applications, and have used a creative combination of licensing and funding to build a strong portfolio in that area. Working with bacterial proteins helps Trius to leverage structure-based drug design (SBDD) technologies to efficiently optimize lead compounds. Dr. John Finn, Trius’ Chief Scientific Officer (bio), will present a talk titled “Innovative Antibacterial Drugs by Design; …

More...